Albemarle Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 9/6/2026)
| Balance Sheet | Total Assets | 16,374,200,000.00 | ROE | 59.74 % |
| Balance Sheet | Total Equity | 9,533,365,000.00 | ROA | -3.12 % |
| Cashflow | Capital Expenditures | -556,989,000.00 | P/FCF | 16.65 |
| Cashflow | Free Cash Flow | 692,468,992.00 | – | – |
| Cashflow | Operating Cash Flow | 1,282,270,000.00 | P/CF | 8.99 |
| Income | Earnings per Share (diluted) | -5.76 | Div. Yield | 1.65 % |
| Income | Net Income | -510,628,000.00 | P/E | -22.57 |
| Income | Shares Outstanding | 117,716,000.00 | P/B | 1.18 |
| Income | Total Revenue | 5,142,730,000.00 | P/S | 2.24 |
Ratios calculated on: 10/14/2026
Company Description
Albemarle Corporation (Albemarle) is a developer, manufacturer and marketer of specialty chemicals, which meet customer needs across a range of end markets, including the petroleum refining, consumer electronics, plastics/packaging, construction, automotive, lubricants, pharmaceuticals, crop protection, food-safety and custom chemistry services markets. As of December 31, 2011, the Company and its joint ventures operated 50 facilities, encompassing production, research and development facilities, and administrative and sales offices in North and South America, Europe, the Middle East, Asia, Africa and Australia. It serves approximately 3,000 customers in over 100 countries. It operates in three segments: Polymer Solutions, Catalysts and Fine Chemistry. On May 11, 2011, the Company acquired Catilin Inc. In October 2013, Albemarle Corp acquired Cambridge Chemical Co Ltd.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.albemarle.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more